Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Trump signs memo to crack down on direct-to-consumer pharma ads

The Trump administration issued about 100 enforcement letters targeting misleading pharmaceutical ads and plans to close a 1997 loophole allowing omission of side effects disclosures.

  • President Donald Trump signed an executive memorandum ordering action on misleading direct-to-consumer drug advertising to ensure transparency and accuracy in ads.
  • President Donald Trump signed a memorandum directing the Department of Health and Human Services to ensure transparency and accuracy in direct-to-consumer drug advertising.
Insights by Ground AI

36 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 41% of the sources are Center
41% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Forbes broke the news in United States on Tuesday, September 9, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal